Definitive Contract 75F40121C00144
Award Date
9/13/21
Potential Completion Date
9/29/26
Potential Value
$4.9M
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to the Commonwealth Scientific and Industrial Research Organisation (CSIRO), a non-profit organization based in Australia. The $300,000.00 firm fixed price contract is for CSIRO to conduct research and development assessing the security and compliancy of ROS-M applications. The contract does not have a set-aside designation and was awarded on April 1, 2019 with a...
This is a firm fixed-price purchase order contract awarded by the Research, Development and Engineering Command (RDECOM), a component of the U.S. Department of Defense, to the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national science agency. The contract, valued at $90,000.00, is for an "ITC-PAC R & D PROJECT 'DNAN'" and does not have a set-aside designation. The contract involves scientific research and development services, which is...
This is a $3,956,154 cost-no-fee definitive contract awarded by the Food and Drug Administration (FDA) to The Leland Stanford Junior University (Stanford University) on September 30, 2020. The contract is for pathology and pathogenesis research on coronavirus infections in animal models, with a performance period through September 30, 2025. The contract was issued under a Broad Agency Announcement (BAA) from the FDA that solicits advanced research and development proposals to support...
This is a $84,395.00 firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to the Commonwealth Scientific and Industrial Research Organisation (CSIRO), a non-profit organization based in Australia. The contract is for MAIA MAPPER XRF ANALYSIS services and has an ultimate completion date of September 30, 2028. There is no set-aside designation for this award. CSIRO, which is Australia's national science agency, has a history of providing diverse...
This is a $1,234,519.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA) to the University of Sydney, an educational institution based in Australia. The contract is for improving scientific approaches to evaluate generic drugs, which aligns with the FDA's Center for Drug Evaluation and Research (CDER) mission. The contract has a period of performance through September 29, 2026 and was awarded on September 27, 2022 without a set-aside designation. The University of...
This is a purchase order contract awarded by the Central Program Planning Coordination and Support (VPARSCPPCS-A) component of the U.S. Department of Agriculture to the Commonwealth Scientific and Industrial Research Organisation (CSIRO), an Australian non-profit research organization, for $65,582.74. The contract is for electronic access to scientific journals and publishing agreements, and has a firm fixed price with a period of performance ending on June 30, 2024. The contract was awarded...
This is a $37,000.00 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences, part of the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization, for compound testing and cytotoxicity screening related to SARS-CoV-2. The contract does not have a set-aside designation. Through past federal contracts and grants, Southern Research has provided a range of research and development services...
This is a definitive cost-plus-fixed-fee contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Physical Sciences Inc., a for-profit research and development company. The contract was awarded under FDA Broad Agency Announcement BAA-18-00123, titled "Single Vial Mass Flow Rate Sensor Assessment of Freeze Drying Heterogeneity", with Proposal Number PMQWP#195. The contract has a potential value of $959,248.00 and a completion date of December...
This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...
This is a cost-plus-fixed-fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to the Southern Research Institute, a non-profit research organization. The $2,029,050.28 contract is for the development of animal models to evaluate medical countermeasures for SARS-CoV-2. The work is being performed under a larger Biological Animal Model Development 2017-2022 indefinite delivery/indefinite quantity (IDIQ) contract with ASPR. This contract has no...